Panacea Biotec Ltd
NSE :PANACEABIO BSE :531349 Sector : PharmaceuticalsBuy, Sell or Hold PANACEABIO? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
10 Jan 437.95 (-0.69%) | 09 Jan 441.00 (-1.58%) | 08 Jan 448.10 (-0.13%) | 07 Jan 448.70 (0.91%) | 06 Jan 444.65 (0.33%) | 03 Jan 443.20 (3.43%) | 02 Jan 428.50 (-2.50%) | 01 Jan 439.50 (4.99%) | 31 Dec 418.60 (0.06%) | 30 Dec 418.35 (-1.99%) | 27 Dec 426.85 (-4.98%) | 26 Dec 449.20 (3.68%) | 24 Dec 433.25 (0.97%) | 23 Dec 429.10 (-4.25%) | 20 Dec 448.15 (-2.24%) | 19 Dec 458.40 (0.46%) | 18 Dec 456.30 (-0.94%) | 17 Dec 460.65 (-5.00%) | 16 Dec 484.90 (3.79%) | 13 Dec 467.20 (0.38%) | 12 Dec 465.45 (-1.03%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bearish
443.08
10 DMA
Bearish
436.2
20 DMA
Bearish
444.09
50 DMA
Bullish
418.78
100 DMA
Bullish
352.24
200 DMA
Bullish
244.9
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Jan 10, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 475.04 | 460.02 | 445.11 | - | - |
R2 | 460.02 | 450.07 | 442.73 | 461.01 | - |
R1 | 448.99 | 443.92 | 440.34 | 450.97 | 454.5 |
P | 433.97 | 433.97 | 433.97 | 434.96 | 436.73 |
S1 | 422.94 | 424.02 | 435.56 | 424.92 | 428.45 |
S2 | 407.92 | 417.87 | 433.17 | 408.91 | - |
S3 | 396.89 | 407.92 | 430.79 | - | - |
Key Metrics
EPS
0
P/E
0
P/B
8.39
Dividend Yield
0%
Market Cap
2,682 Cr.
Face Value
1
Book Value
51.69
ROE
-4.07%
EBITDA Growth
13.42 Cr.
Debt/Equity
0.02
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Panacea Biotec Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 149.02 | 158.96 | 150.01 | 122.26 | 154.77 | |
PROFIT | -10.88 | -4.36 | -4.66 | -18.62 | 1.97 | |
EPS | -1.35 | -0.37 | -0.23 | -2.59 | 0.77 |
Panacea Biotec Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 96.72 | 98.28 | 96.76 | 60.68 | 80.05 | |
PROFIT | 3.2 | 0.43 | -1.37 | -13.78 | 1.29 | |
EPS | 0.52 | 0.07 | -0.22 | -2.25 | 0.21 |
Profit & Loss (Figures in Rs. Crores)
Panacea Biotec Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 700.81 | 700.9 | 607.49 | 611.51 | 758.16 | 607.3 | 629.25 | 2397.38 | 579.9 | 603.14 | |
PROFIT | -105.96 | -66.53 | -62.36 | -73.98 | -288.05 | -159.82 | -147.66 | -197 | -94.64 | -33.96 | |
EPS | 0 | 0 | 0 | 0 | 5.64 | -29.1 | -24.11 | 176.05 | -5.51 | -0.25 |
Panacea Biotec Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 680.86 | 700.6 | 601.1 | 271.48 | 400.59 | 217.15 | 350.07 | 309.02 | 260.36 | 366.72 | |
PROFIT | -65.1 | -48.78 | -34.74 | -71.88 | -276.22 | -121.7 | -17.7 | -93.59 | -92.84 | 3.5 | |
EPS | 0 | 0.13 | 0 | 0 | 3.98 | -22.93 | -2.36 | -15.28 | -14.29 | 0.58 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 12.12 | 11.11 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | 22.43 | 22.43 |
Reserves Total | 814.27 | 815.82 | 848.86 | -256.47 | 138.87 | 334.63 | 292.91 | 339.91 | 426.18 | 448.76 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 |
Equity Application Money | 21.65 | 21.65 | 21.65 | 21.65 | 21.79 | 9.64 | 9.64 | 9.64 | 0 | 0.1 |
Total Shareholders Funds | 848.04 | 848.58 | 876.64 | -228.69 | 198.79 | 350.4 | 308.68 | 355.68 | 448.61 | 471.29 |
Minority Interest | -3.82 | -3.49 | -2.98 | -3 | -3.04 | -3.01 | -2.95 | 10.54 | 1.08 | 3.42 |
Secured Loans | 0 | 0.24 | 0.29 | 759.5 | 708.64 | 604.57 | 906.96 | 959.87 | 1,058.16 | 1,059.43 |
Unsecured Loans | 15 | 15 | 33.87 | 60.03 | 33.55 | 41.93 | 33.79 | 33.71 | 30.27 | 35.45 |
Total Debt | 15 | 15.24 | 34.16 | 819.53 | 742.19 | 646.5 | 940.75 | 993.58 | 1,088.43 | 1,094.88 |
Other Liabilities | 50.08 | 60.79 | 74.74 | 225.05 | 129.48 | 43.75 | 30.83 | 120.64 | 62.34 | 26.28 |
Total Liabilities | 909.3 | 921.12 | 982.56 | 812.89 | 1,067.42 | 1,037.64 | 1,277.31 | 1,480.44 | 1,600.46 | 1,595.87 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 1,326.51 | 1,330.83 | 1,317.48 | 1,261.62 | 1,274.64 | 1,392.9 | 1,605.84 | 1,600.07 | 1,620.29 | 1,633.48 |
Less: Accumulated Depreciation | 744.66 | 730.88 | 695.41 | 652.92 | 617.25 | 587.34 | 656.87 | 598.7 | 549.18 | 489.18 |
Net Block | 581.85 | 599.95 | 622.07 | 608.7 | 657.39 | 805.56 | 948.97 | 1,001.37 | 1,071.11 | 1,144.3 |
Capital Work in Progress | 101.5 | 42.32 | 17.26 | 34.42 | 24.01 | 22.51 | 39.93 | 30.41 | 160.95 | 155.48 |
Investments | 40.43 | 13.49 | 5.07 | 0.07 | 5.58 | 5.33 | 7.28 | 7.28 | 8.71 | 15.18 |
Inventories | 177.94 | 202.09 | 212.72 | 174.14 | 147.69 | 81.43 | 334.21 | 315.55 | 305.24 | 310.22 |
Sundry Debtors | 57.42 | 60.09 | 81.66 | 84.68 | 68.52 | 88.73 | 136.01 | 142.17 | 141.67 | 98.57 |
Cash and Bank Balance | 139.48 | 225.99 | 583.28 | 135.79 | 89.75 | 23.48 | 23.24 | 14.13 | 22.93 | 52.4 |
Loans and Advances | 69.98 | 60.73 | 67.9 | 116.36 | 377.31 | 314.25 | 64.87 | 61.31 | 76.02 | 59.55 |
Total Current Assets | 444.82 | 548.9 | 945.56 | 510.97 | 683.27 | 507.89 | 558.32 | 533.17 | 545.86 | 520.74 |
Current Liabilities | 273.01 | 292.97 | 740.28 | 351.27 | 315.48 | 323.97 | 314.04 | 299.8 | 251.94 | 327.91 |
Provisions | 35.82 | 36.7 | 36.03 | 13.37 | 7.41 | 13.92 | 6.95 | 8.81 | 1.51 | 6.21 |
Total Current Liabilities & Provisions | 308.83 | 329.67 | 776.32 | 364.65 | 322.89 | 337.89 | 320.99 | 308.61 | 253.45 | 334.12 |
Net Current Assets | 135.99 | 219.23 | 169.24 | 146.32 | 360.38 | 170 | 237.33 | 224.56 | 292.41 | 186.62 |
Deferred Tax Assets | 76.72 | 79.89 | 127.44 | 120.28 | 135.63 | 167.22 | 219.22 | 246.7 | 84.03 | 89.11 |
Deferred Tax Liability | 99.27 | 100.26 | 103.69 | 120.13 | 133.68 | 147.43 | 208.82 | 228.29 | 84.53 | 89.59 |
Net Deferred Tax | -22.55 | -20.37 | 23.75 | 0.15 | 1.95 | 19.79 | 10.4 | 18.41 | -0.5 | -0.48 |
Other Assets | 72.08 | 66.5 | 145.16 | 23.23 | 18.11 | 14.45 | 33.4 | 198.41 | 67.78 | 94.77 |
Total Assets | 909.3 | 921.13 | 982.55 | 812.89 | 1,067.41 | 1,037.64 | 1,277.31 | 1,480.44 | 1,600.46 | 1,595.87 |
Contingent Liabilities | 369.39 | 655.75 | 368.17 | 406.99 | 366.93 | 404.06 | 378.64 | 364.27 | 353.54 | 353.5 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 12.12 | 11.11 | 6.13 | 6.13 | 6.13 | 6.13 | 15.59 | 6.13 | 22.43 | 22.43 |
Reserves Total | 301.36 | 297.87 | 387.32 | 480.39 | 832.82 | 402.71 | 372.33 | 440.06 | 517.6 | 517.28 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 |
Equity Application Money | 21.65 | 21.65 | 21.65 | 21.65 | 21.79 | 9.64 | 9.64 | 9.64 | 0 | 0 |
Total Shareholders Funds | 335.13 | 330.63 | 415.1 | 508.17 | 892.74 | 418.48 | 397.56 | 455.83 | 540.03 | 539.71 |
Secured Loans | 0 | 0.24 | 0.29 | 5.05 | 12.44 | 604.57 | 906.96 | 959.87 | 962.38 | 955.95 |
Unsecured Loans | 118.87 | 97.23 | 83.87 | 60.03 | 54.8 | 84.11 | 53.27 | 62.65 | 56.71 | 58.81 |
Total Debt | 118.87 | 97.47 | 84.16 | 65.08 | 67.24 | 688.68 | 960.23 | 1,022.52 | 1,019.09 | 1,014.76 |
Other Liabilities | 25.85 | 20.21 | 15.88 | 20.52 | 17.97 | 14.17 | 29.42 | 21.97 | 14.52 | 12.38 |
Total Liabilities | 479.85 | 448.31 | 515.14 | 593.77 | 977.95 | 1,121.33 | 1,387.21 | 1,500.32 | 1,573.64 | 1,566.85 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 900.61 | 908.57 | 907.86 | 893.02 | 905.42 | 813.95 | 1,542.55 | 1,536.97 | 1,518.16 | 1,532.12 |
Less : Accumulated Depreciation | 477.58 | 473.21 | 453.83 | 428.77 | 406.14 | 317.52 | 651.62 | 594.95 | 530.58 | 472.44 |
Net Block | 423.03 | 435.36 | 454.03 | 464.25 | 499.28 | 496.43 | 890.93 | 942.02 | 987.58 | 1,059.68 |
Capital Work in Progress | 96.54 | 27.85 | 0.88 | 12.97 | 3.74 | 3.1 | 37.16 | 27.68 | 19.01 | 16.98 |
Investments | 0.27 | 0.27 | 0.27 | 0.27 | 2.55 | 2.54 | 344.88 | 344.88 | 394.66 | 394.66 |
Inventories | 107.93 | 116.1 | 129.25 | 87.04 | 99.23 | 42.51 | 149.1 | 140.6 | 136.57 | 140.9 |
Sundry Debtors | 11.08 | 12.27 | 23.32 | 35.29 | 17.69 | 25.2 | 142.27 | 175.8 | 142.21 | 100.43 |
Cash and Bank Balance | 29.44 | 43.25 | 42.69 | 88.96 | 60.61 | 7.85 | 11.79 | 7.21 | 9.32 | 42.37 |
Loans and Advances | 34.76 | 27.52 | 53.57 | 81.26 | 436.8 | 840.55 | 50.5 | 80.08 | 53.01 | 31.47 |
Total Current Assets | 183.2 | 199.14 | 248.82 | 292.55 | 614.32 | 916.1 | 353.65 | 403.7 | 341.11 | 315.17 |
Current Liabilities | 219.02 | 222.06 | 217.84 | 192.08 | 157.44 | 311.05 | 279.5 | 279.99 | 232.42 | 307.23 |
Provisions | 29.97 | 28.74 | 28.86 | 4.44 | 3.1 | 9.66 | 6.79 | 1.45 | 1.37 | 5.15 |
Total Current Liabilities & Provisions | 248.98 | 250.79 | 246.7 | 196.52 | 160.54 | 320.72 | 286.29 | 281.45 | 233.79 | 312.38 |
Net Current Assets | -65.78 | -51.66 | 2.12 | 96.03 | 453.77 | 595.39 | 67.36 | 122.25 | 107.32 | 2.79 |
Deferred Tax Assets | 46.02 | 46.02 | 72.09 | 0 | 135.13 | 166.64 | 203.13 | 234.63 | 84.03 | 89.11 |
Deferred Tax Liability | 70.82 | 70.82 | 72.09 | 0 | 133.68 | 147.43 | 181.14 | 202.76 | 84.03 | 89.11 |
Net Deferred Tax | -24.8 | -24.8 | 0 | 0 | 1.45 | 19.21 | 21.99 | 31.87 | 0 | 0 |
Other Assets | 50.6 | 61.3 | 57.83 | 20.25 | 17.16 | 4.65 | 24.89 | 31.61 | 65.07 | 92.74 |
Total Assets | 479.86 | 448.31 | 515.13 | 593.77 | 977.95 | 1,121.33 | 1,387.21 | 1,500.31 | 1,573.64 | 1,566.85 |
Contingent Liabilities | 369.39 | 655.75 | 368.17 | 406.99 | 366.93 | 404.06 | 378.64 | 364.27 | 353.54 | 353.5 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 1.48 |
Depreciation | 36.71 |
Interest (Net) | -4.79 |
Dividend Received | 0.01 |
P/L on Sales of Assets | 4.56 |
P/L on Sales of Invest | -3.37 |
Prov. and W/O (Net) | -5.96 |
P/L in Forex | 0.13 |
Total Adjustments (PBT and Ext... | -8.76 |
Operating Profit before Workin... | -7.28 |
Trade and 0ther Receivables | 2.96 |
Inventories | 24.16 |
Loans and Advances | -27.96 |
Total Adjustments (OP before W... | 9.69 |
Cash Generated from/(used in) ... | 2.41 |
Direct Taxes Paid | -2.51 |
Total Adjustments(Cash Generat... | -2.51 |
Cash Flow before Extraordinary... | -0.1 |
Net Cash from Operating Activi... | -0.1 |
Purchased of Fixed Assets | -77.72 |
Sale of Fixed Assets | 6.68 |
Purchase of Investments | -301.66 |
Sale of Investments | 278.09 |
Interest Received | 8.37 |
Inter Corporate Deposits | 142.05 |
Net Cash used in Investing Act... | 10.23 |
Of the Long Tem Borrowings | -0.24 |
Interest Paid | -2.57 |
Net Cash used in Financing Act... | -2.81 |
Net Profit before Tax and Extr... | 4.21 |
Depreciation | 21.09 |
Interest (Net) | -1.44 |
Dividend Received | 0.01 |
P/L on Sales of Assets | 0.45 |
Prov. and W/O (Net) | 10.08 |
P/L in Forex | 0.79 |
Total Adjustments (PBT and Ext... | 30.95 |
Operating Profit before Workin... | 35.16 |
Trade and 0ther Receivables | 1.28 |
Inventories | 8.17 |
Loans and Advances | -7.95 |
Total Adjustments (OP before W... | 4 |
Cash Generated from/(used in) ... | 39.15 |
Direct Taxes Paid | -1.88 |
Total Adjustments(Cash Generat... | -1.88 |
Cash Flow before Extraordinary... | 37.27 |
Net Cash from Operating Activi... | 37.27 |
Purchased of Fixed Assets | -75.03 |
Sale of Fixed Assets | 6.64 |
Interest Received | 3.72 |
Net Cash used in Investing Act... | -51.01 |
Proceed from 0ther Long Term B... | 215.34 |
Of the Long Tem Borrowings | -193.93 |
Interest Paid | -8.59 |
Net Cash used in Financing Act... | 12.82 |
Company Details
Registered Office |
|
Address | Ambala-Chandigarh Highway, |
City | Lalru |
State | Punjab |
Pin Code | 140501 |
Tel. No. | 91-1762-505900 |
Fax. No. | |
corporate@panaceabiotec.com; investorgrievances@pa | |
Internet | http://www.panaceabiotec.com |
Registrars |
|
Address | Ambala-Chandigarh Highway |
City | Lalru |
State | Punjab |
Pin Code | 140501 |
Tel. No. | 91-1762-505900 |
Fax. No. | |
corporate@panaceabiotec.com; investorgrievances@pa | |
Internet | http://www.panaceabiotec.com |
Management |
|
Name | Designation |
Rajesh Jain | Chairman & Managing Director |
Sandeep Jain | Joint Managing Director |
Vinod Goel | Group CFO & Company Secretary |
Manjula Upadhyay | Non-Exec. & Independent Dir. |
Mukul Gupta | Non-Exec. & Independent Dir. |
Ankesh Jain | Whole-time Director |
BHUPINDER SINGH | Non-Exec. & Independent Dir. |
Narotam Kumar Juneja | Non Executive Director |
Ambika Sharma | Independent Director |